
Rare Disease Week
February 24, 2022
BioUtah is pleased to recognize Rare Disease Day, designated as February 28. There are approximately 7,000 rare diseases, affecting an estimated 25 million to 30 million Americans. Only five percent of these diseases have a treatment.
The mantra of the National Organization for Rare Disorders (NORD) – “Alone we are rare. Together we are strong” – reflects the impetus behind a law passed in 2019 by the Utah legislature to establish a Utah Rare Disease Advisory Council (RDAC). The Utah RDAC held its first meeting last year, in October, and has been meeting on a bi-monthly basis to address the needs of the state’s rare disease community.
Under the umbrella of Utah’s Department of Health, the aim of the advisory council is to bring stakeholders together – policymakers, patients, caregivers, physicians, nurses, insurers, researchers and industry – to make a difference for patients with rare disease.
“It’s important that we join together to give voice to those struggling with rare disease,” said Kelvyn Cullimore, president and CEO of BioUtah. “In many ways, our life sciences sector is a critical partner, working to develop the diagnostics and therapies that will help improve the lives of these patients.”
Recent News
- RefloDx Closes $2 Million Seed Round to Advance Noninvasive Testing for Chronic Throat and Voice Symptoms
- Myriad Genetics Releases New MONSTAR-SCREEN-3 Data Demonstrating the Potential of Ultra-Sensitive MRD Detection in Colorectal and Pancreatic Cancers
- Ultragenyx sells second rare pediatric PRV in a week for $203M
- Co-Diagnostics’ Joint Venture CoMira Diagnostics Invited by Saudi Ministry to Participate in Strategic Manufacturing Forum
- Route 92 Medical Announces $100 Million Corporate Debt Facility
- Myriad Genetics and Labcorp Announce Definitive Agreement for Myriad to Sell Prenatal Health Testing Business to Labcorp














